Abstract
The present study examined the effects of ATP on the striatum of Sprague-Dawley rats. Intrastriatal administration of ATP produced dose-dependent striatal lesions as confirmed by cresyl violet staining. Additional immunostaining using neuronal nuclear protein (NeuN), OX-42 and GFAP antibodies revealed that ATP caused death of both neurons and glial cells. The nonmetabolizable ATP analogue ATPgammaS and P2X receptor agonist alpha,beta-methylene ATP (alpha,beta-MeATP) mimicked ATP effects, whereas either P2Y receptor agonist ADP or P1 receptor agonist adenosine did not. The P2 receptor antagonist reactive blue 2, but not pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) attenuated ATP-induced striatal injury. These results suggest that intrastriatal administration of ATP causes P2X receptor-mediated cell death in the striatum and support the hypothesis that extracellular ATP can be an important mediator of neuropathological events of brain injuries.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine Triphosphate / analogs & derivatives
-
Adenosine Triphosphate / metabolism*
-
Adenosine Triphosphate / pharmacology
-
Animals
-
Antigens, CD*
-
Antigens, Neoplasm*
-
Antigens, Surface*
-
Astrocytes / drug effects
-
Astrocytes / metabolism
-
Astrocytes / pathology
-
Avian Proteins*
-
Basigin
-
Blood Proteins*
-
Cell Death / drug effects
-
Cell Death / physiology
-
Dose-Response Relationship, Drug
-
Female
-
Glial Fibrillary Acidic Protein / metabolism
-
Hypoxia-Ischemia, Brain / metabolism*
-
Hypoxia-Ischemia, Brain / physiopathology
-
Membrane Glycoproteins / metabolism
-
Microglia / drug effects
-
Microglia / metabolism
-
Microglia / pathology
-
Neostriatum / drug effects
-
Neostriatum / metabolism*
-
Neostriatum / physiopathology
-
Nerve Degeneration / chemically induced
-
Nerve Degeneration / metabolism
-
Nerve Degeneration / physiopathology
-
Neuroglia / drug effects
-
Neuroglia / metabolism*
-
Neuroglia / pathology
-
Neurons / drug effects
-
Neurons / metabolism*
-
Neurons / pathology
-
Neurotoxins / metabolism*
-
Neurotoxins / toxicity
-
Purinergic P1 Receptor Agonists
-
Purinergic P1 Receptor Antagonists
-
Purinergic P2 Receptor Agonists
-
Purinergic P2 Receptor Antagonists
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Purinergic P1 / metabolism
-
Receptors, Purinergic P2 / metabolism*
-
Receptors, Purinergic P2X
Substances
-
Antigens, CD
-
Antigens, Neoplasm
-
Antigens, Surface
-
Avian Proteins
-
Blood Proteins
-
Bsg protein, Gallus gallus
-
Bsg protein, rat
-
Glial Fibrillary Acidic Protein
-
Membrane Glycoproteins
-
Neurotoxins
-
Purinergic P1 Receptor Agonists
-
Purinergic P1 Receptor Antagonists
-
Purinergic P2 Receptor Agonists
-
Purinergic P2 Receptor Antagonists
-
Receptors, Purinergic P1
-
Receptors, Purinergic P2
-
Receptors, Purinergic P2X
-
Basigin
-
Adenosine Triphosphate